Mitigating the risk of transfusion‐transmitted infections with vector‐borne agents solely by means of pathogen reduction

Author:

Stramer Susan L.1ORCID,Lanteri Marion C.2ORCID,Brodsky Jaye P.3,Foster Gregory A.1,Krysztof David E.1,Groves Jamel A.1,Townsend Rebecca L.1,Notari Edward4,Bakkour Sonia5ORCID,Stone Mars5,Simmons Graham5,Spencer Bryan6ORCID,Tonnetti Laura4ORCID,Busch Michael P.5

Affiliation:

1. American Red Cross, Scientific Affairs Gaithersburg Maryland USA

2. Cerus Corporation Concord California USA

3. Quality Analytics Riverwoods Illinois USA

4. American Red Cross, Scientific Affairs Rockville Maryland USA

5. Vitalant Research Institute San Francisco California USA

6. American Red Cross, Scientific Affairs Dedham Massachusetts USA

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Reference73 articles.

1. INTERCEPT® blood system for plasma package insert Concord CA: Cerus Corporation;2020.

2. INTERCEPT® blood system for platelets package insert Concord CA: Cerus Corporation;2019.

3. U.S Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research.Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion ‐ guidance for industry.2020.

4. U.S Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research.Recommendations for donor screening deferral and product management to reduce the risk of transfusion transmission of Zika virus ‐ guidance for industry.2016.http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM486360.pdf.

5. U.S Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research.Recommendations for reducing the risk of transfusion‐transmitted Babesiosis ‐ guidance for industry.2019.https://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3